vs
Global Indemnity Group, LLC（GBLI）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
Global Indemnity Group, LLC的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$116.7M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 7.6%），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 2.0%）
Global Indemnity Group LLC是一家专业保险控股企业，提供定制化商业及个人财产意外险产品、保证保险与再保险解决方案，主要服务美国境内中小微企业及小众个人保险客群，聚焦传统保险覆盖不足的特殊风险领域。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
GBLI vs PBYI — 直观对比
营收规模更大
GBLI
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出20.1%
7.6%
两年增速更快
PBYI
近两年复合增速
2.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $116.7M | $75.5M |
| 净利润 | $6.5M | — |
| 毛利率 | — | 69.3% |
| 营业利润率 | 7.9% | 22.7% |
| 净利率 | 5.5% | — |
| 营收同比 | 7.6% | 27.7% |
| 净利润同比 | -28.5% | — |
| 每股收益（稀释后） | $0.48 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GBLIPBYI
| Q4 25 | $116.7M | $75.5M | ||
| Q3 25 | $114.2M | $54.5M | ||
| Q2 25 | $110.5M | $52.4M | ||
| Q1 25 | $108.7M | $46.0M | ||
| Q4 24 | $108.4M | $59.1M | ||
| Q3 24 | $111.8M | $80.5M | ||
| Q2 24 | $108.7M | $47.1M | ||
| Q1 24 | $112.3M | $43.8M |
净利润GBLIPBYI
| Q4 25 | $6.5M | — | ||
| Q3 25 | $12.5M | $8.8M | ||
| Q2 25 | $10.3M | $5.9M | ||
| Q1 25 | $-4.0M | $3.0M | ||
| Q4 24 | $9.0M | — | ||
| Q3 24 | $12.8M | $20.3M | ||
| Q2 24 | $10.1M | $-4.5M | ||
| Q1 24 | $11.4M | $-4.8M |
毛利率GBLIPBYI
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
营业利润率GBLIPBYI
| Q4 25 | 7.9% | 22.7% | ||
| Q3 25 | 14.1% | 17.6% | ||
| Q2 25 | 11.9% | 12.7% | ||
| Q1 25 | -4.7% | 8.7% | ||
| Q4 24 | 11.2% | 22.6% | ||
| Q3 24 | 14.2% | 27.4% | ||
| Q2 24 | 11.7% | -4.6% | ||
| Q1 24 | 12.7% | -5.3% |
净利率GBLIPBYI
| Q4 25 | 5.5% | — | ||
| Q3 25 | 11.0% | 16.2% | ||
| Q2 25 | 9.4% | 11.2% | ||
| Q1 25 | -3.7% | 6.5% | ||
| Q4 24 | 8.3% | — | ||
| Q3 24 | 11.4% | 25.2% | ||
| Q2 24 | 9.3% | -9.6% | ||
| Q1 24 | 10.1% | -11.0% |
每股收益（稀释后）GBLIPBYI
| Q4 25 | $0.48 | $0.26 | ||
| Q3 25 | $0.86 | $0.17 | ||
| Q2 25 | $0.71 | $0.12 | ||
| Q1 25 | $-0.30 | $0.06 | ||
| Q4 24 | $0.65 | $0.40 | ||
| Q3 24 | $0.92 | $0.41 | ||
| Q2 24 | $0.73 | $-0.09 | ||
| Q1 24 | $0.82 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $65.5M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $706.6M | $130.3M |
| 总资产 | $1.7B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资GBLIPBYI
| Q4 25 | $65.5M | $97.5M | ||
| Q3 25 | $75.4M | $94.4M | ||
| Q2 25 | $67.3M | $96.0M | ||
| Q1 25 | $81.1M | $93.2M | ||
| Q4 24 | $17.0M | $101.0M | ||
| Q3 24 | $31.0M | $96.7M | ||
| Q2 24 | $46.7M | $96.8M | ||
| Q1 24 | $38.9M | $107.2M |
总债务GBLIPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益GBLIPBYI
| Q4 25 | $706.6M | $130.3M | ||
| Q3 25 | $704.1M | $115.3M | ||
| Q2 25 | $695.3M | $104.7M | ||
| Q1 25 | $687.1M | $97.1M | ||
| Q4 24 | $689.1M | $92.1M | ||
| Q3 24 | $686.7M | $71.1M | ||
| Q2 24 | $667.5M | $48.5M | ||
| Q1 24 | $659.5M | $51.0M |
总资产GBLIPBYI
| Q4 25 | $1.7B | $216.3M | ||
| Q3 25 | $1.7B | $202.9M | ||
| Q2 25 | $1.7B | $194.9M | ||
| Q1 25 | $1.7B | $196.2M | ||
| Q4 24 | $1.7B | $213.3M | ||
| Q3 24 | $1.8B | $220.7M | ||
| Q2 24 | $1.7B | $205.0M | ||
| Q1 24 | $1.7B | $214.1M |
负债/权益比GBLIPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $9.1M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | — | $14.4M |
| 自由现金流率自由现金流/营收 | — | 19.1% |
| 资本支出强度资本支出/营收 | — | 0.0% |
| 现金转化率经营现金流/净利润 | 1.40× | — |
| 过去12个月自由现金流最近4个季度 | — | $41.7M |
8季度趋势，按日历期对齐
经营现金流GBLIPBYI
| Q4 25 | $9.1M | $14.4M | ||
| Q3 25 | $5.7M | $9.7M | ||
| Q2 25 | $7.0M | $14.1M | ||
| Q1 25 | $2.4M | $3.6M | ||
| Q4 24 | $38.8M | $15.6M | ||
| Q3 24 | $15.3M | $11.0M | ||
| Q2 24 | $14.3M | $1.0M | ||
| Q1 24 | $22.7M | $11.2M |
自由现金流GBLIPBYI
| Q4 25 | — | $14.4M | ||
| Q3 25 | — | $9.7M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | — | $3.6M | ||
| Q4 24 | — | $15.6M | ||
| Q3 24 | — | $11.0M | ||
| Q2 24 | — | $1.0M | ||
| Q1 24 | — | — |
自由现金流率GBLIPBYI
| Q4 25 | — | 19.1% | ||
| Q3 25 | — | 17.7% | ||
| Q2 25 | — | 26.8% | ||
| Q1 25 | — | 7.7% | ||
| Q4 24 | — | 26.4% | ||
| Q3 24 | — | 13.7% | ||
| Q2 24 | — | 2.1% | ||
| Q1 24 | — | — |
资本支出强度GBLIPBYI
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.0% | ||
| Q2 25 | — | 0.0% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | 0.0% | ||
| Q1 24 | — | 0.0% |
现金转化率GBLIPBYI
| Q4 25 | 1.40× | — | ||
| Q3 25 | 0.45× | 1.10× | ||
| Q2 25 | 0.68× | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | 4.30× | — | ||
| Q3 24 | 1.20× | 0.54× | ||
| Q2 24 | 1.41× | — | ||
| Q1 24 | 2.00× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GBLI
| Belmont Core | $99.2M | 85% |
| Agency And Insurance Services | $13.8M | 12% |
| Other | $3.7M | 3% |
PBYI
暂无分部数据
